Literature DB >> 8738279

Genomic variation in Trypanosoma cruzi clonal cultures.

A M Alves1, D F de Almeida, W M von Krüger.   

Abstract

Spontaneous changes in restriction DNA profiles and pulsed-field gel electrophoresis (PFGE) patterns, along with a concomitant loss of infectivity, were observed in infective clones of Trypanosoma cruzi strain Y either following a number of passages during the exponential growth phase of after subcloning in liver infusion tryptone (LIT) medium using as the probe a genomic fragment of the parasite (pMYP16), indicating naturally occurring rearrangements of DNA sequences. No variation could be detected when the genomic DNA was probed with conserved T. cruzi tubulin and actin genes. There was no correlation between such rearrangements and the life-cycle forms of the parasites, since trypomastigote forms showed the same karyotype and hybridization patterns as did epimastigote forms. The variations observed could be reverted and infectivity, recovered after inoculation of the parasites in newborn mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738279     DOI: 10.1007/s004360050137

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  38 in total

1.  Transkinetoplastidy--a novel phenomenon involving bulk alterations of mitochondrion-kinetoplast DNA of a trypanosomatid protozoan.

Authors:  S Y Lee; S T Lee; K P Chang
Journal:  J Protozool       Date:  1992 Jan-Feb

2.  Multiple forms of chromosome I, II and V in a restricted population of Leishmania infantum contrasting with monomorphism in individual strains suggest haploidy or automixy.

Authors:  C Blaineau; P Bastien; M Pagès
Journal:  Mol Biochem Parasitol       Date:  1992-02       Impact factor: 1.759

3.  Effect of culture conditions and bacterial associates on the zymodemes of Entamoeba histolytica.

Authors:  D Mirelman
Journal:  Parasitol Today       Date:  1987-02

4.  Alpha- and beta-tubulin mRNAs of Trypanosoma cruzi originate from a single multicistronic transcript.

Authors:  C M Soares; E F de Carvalho; T P Urményi; J F Carvalho; F T de Castro; E Rondinelli
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

5.  Repetitive DNA elements characteristic of pathogenic Entamoeba histolytica strains can also be detected after polymerase chain reaction in a cloned nonpathogenic strain.

Authors:  D Mirelman; R Bracha; S Rozenblatt; L I Garfinkel
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Zymodeme conversion of isolates of Entamoeba histolytica.

Authors:  B J Andrews; L Mentzoni; B Bjorvatn
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jan-Feb       Impact factor: 2.184

7.  DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes.

Authors:  L I Garfinkel; M Giladi; M Huber; C Gitler; D Mirelman; M Revel; S Rozenblatt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

8.  DNA methylation in Trypanosoma cruzi.

Authors:  M V Rojas; N Galanti
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

9.  Characterization of sequence changes in kinetoplast DNA maxicircles of drug-resistant Leishmania.

Authors:  S T Lee; C Tarn; C Y Wang
Journal:  Mol Biochem Parasitol       Date:  1992-12       Impact factor: 1.759

10.  Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles.

Authors:  C Morel; E Chiari; E P Camargo; D M Mattei; A J Romanha; L Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  1 in total

1.  Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi.

Authors:  H R Martins; R Moreira Silva; H M S Valadares; M J O Toledo; V M Veloso; D M Vitelli-Avelar; C M Carneiro; G L L Machado-Coelho; M T Bahia; O A Martins-Filho; A M Macedo; M Lana
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.